SAPHO syndrome the therapeutical challenge

Bogdan Dejanović ,
Bogdan Dejanović
Gorica Ristić Orcid logo ,
Gorica Ristić
Vladan Perić ,
Vladan Perić
Zlatica Petković ,
Zlatica Petković
Gordana Nikolić ,
Gordana Nikolić
Ninoslav Dejanović
Ninoslav Dejanović

Published: 01.01.2016.

Volume 45, Issue 1 (2016)

pp. 73-76;

https://doi.org/10.5937/pramed1601073d

Abstract

Introduction: Sapho syndorm is a syndrom characterizing with osteoarticular end dermatologic symptoms. Acronym „SAPHO“ means: S-Sinovitis, A-Acne, H-Hyperostosis, O-Osteytis. SAPHO syndrom has a 50 different names in existing literature. For now, etiology remains unclear, but it belongs to group of seronegative spondylarthropathies. Therapy of SAPHO includes NSAIL, glucocorticosteroids, disease modifying anthireumatic drugs (DMARD), antibiotics, bifosfonatos, and anti TNF - alfa drugs with variable success. Case outline: Pacent P.Z, 47 age, female, comes in the hospital, because of pain in anterior chest, with propagation in right arm, end morning stiffness in sacral part, which passes short after. Also, with recidivant pustules on the palms, bilaterally, which precedes itch. Bone scintigraphy was performed: There is a clear increasing binding of radiopharmacs in projection of strenoclavicular joint, and slightly in both shoulders and both knees. HP: Pustulosis palmoplantaris. We introduced in therapy azithromycin in the dose of 500 mg, two times weekly, for 16 weeks. Patient, one year after, is without relapses of arthritis and skin lesions. Conclusion: This report has goal, to get more knowledge about this rare disease, and to be easier for recognition. Also we want to introduce other physicians, of varying specialities, like orthopaedics, and other surguries, with this disease, not only rheuamatologists, dermatologists, and pediatrics.

Keywords

References

1.
Naročito. da se o ovom entitetu pored reumatologa, dermatologa, pedijatara, upoznaju i ostale komplementarne grane, kao što su, ortopedi, hirurzi i lekari drugih specijalnosti. ZAKLJUČAK.
2.
Chamot A, Benhamou C, Kahn M. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987;187–96.
3.
Schilling F. SAPHO syndrome, Orphanet encyclopedia.
4.
Rukavina I. SAPHO syndrome: a review. J Child Orthop. 2015;19–27.
5.
Rozin A. SAPHO syndrome: Is a range of pathogen-associated rheumatic diseases extended? Arthritis Research & Therapy. 2009;131.
6.
Khanna L, El-Khoury G. syndrome-a pictorial assay. Iowa Orthop J. 2012;189–95.
7.
Thakur U, Blacksin M, Beebe K, Neilson J, Dashefsky B, Tagoylo G. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) and chronic recurrent multifocal osteomyelitis (CRMO): role of imaging in diagnosis. Radiography. 2012;221–4.
8.
Souza D, Solomon A, Strober G, B. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis. 2011;185–7.
9.
Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation:interventional study. Arthritis Res Ther. 2009;
10.
Assmann G, Simon P. The SAPHO syndrome -Are microbes involved. 2011;
11.
Rozin A, Nahir A. Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol. 2007;817–20.
12.
Arnson Y, Rubinow A, Amital H. Secondary syphilis presenting as SAPHO syndrome features. Clin Exp Rheumatol. 2008;1119–21.
13.
Rozin A. From molecular mimicry to cross-reactivity or pathogen expansion? A hypothesis. Clin Rheumatol. 2007;285–8.
14.
Kahn M, Khan M. The SAPHO syndrome. Baillieres Clin Rheumatol. 1994;333–62.
15.
Тюхова А, Бочкова, Братыгина Е, Бунчук Н, Синдром S. 2009;
16.
Assmann G, Sapho.
17.
Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin, Arthritis Rheum. 1999;(3):159–71.
18.
Colina M, Corte L, Trotta R, F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and review of the literature. Clin Exp Rheumatol. 2009;112–5.
19.
Massara A, Cavazzini P, Trotta F. In SAPHO syndrome antiTNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford). 2006;730–3.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by